Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

FDA places Bright Minds’ planned BMB-101 Phase II epilepsy study on partial clinical hold


Impella registry analyses report lower mortality than CHIP-BCIS3 in high-risk PCI


FDA grants Priority Review to uniQure’s Huntington’s disease gene therapy


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Using PAT to accelerate and optimize the process development of solid dosage forms.

Presented by Lizbeth Martinez, Ph. D. Associate Director Data Science, Oral Pharmaceutical Development at Novartis Basel Switzerland and Emiliano Genorini, Account Manager – MicroNIR at Viavi Solutions
04th November 2021


Machine Learning in Bioprocess Development: Where We Are and Where We Could Go

Presented by Rui Portela, Senior Data Scientist, GlaxoSmithKline Vaccines and Klaus Mauch, CEO at Insilico Biotechnology AG
06th May 2020


Mass Transport Modelling in support of leachable risk management

Presented by Thomas Egert, Research Scientist Pharmaceutical Contact Materials at Boehringer Ingelheim Pharma GmbH and and Jason Creasey, Managing Director at Maven E&L Ltd
17th January 2023


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia